Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Q2: What does BPC-157 do
Ovarian cancer is the sixth most common malignancy among women in developed countries and the fifth leading cause of cancer-related death, representing a complex disease associated with poor survival rates.24 The combination chemotherapy of Paclitaxel (PTX) and Carboplatin (CARB) is considered the first-line treatment regimen for ovarian cancer.25 Both agents play distinct roles in inhibiting the growth of ovarian cancer through different mechanisms,26 and they are known to exert a synergistic anti-tumor effect by activating separate apoptotic signaling pathways, thereby potentially reducing drug resistance.25 The gonadotoxic effects of platinum-based chemotherapeutic agents have been demonstrated in numerous studies, both histopathologically and in terms of follicular development.27-29 In the present study, CARB administration led to significant histopathological damage in ovarian tissue, including follicular degeneration, prominent stromal edema, congestion, hemorrhage, inflammation, and fibrosis, particularly in the medullary region
[17] In humans, glutathione synthetase functions in a similar manner
Tyrosinase Inhibitors Help regulate the enzymes responsible for skin pigmentation
Are oral GLP-1s as effective as injections
Weight Loss For individuals living with obesity, weight loss outcomes in early trials consistently exceeded expectations
US$ 25.28
US$ 28.85
US$ 21.62
US$ 24.46
US$ 26.22
US$ 25.35
US$ 21.12
US$ 20.95
US$ 27.57
US$ 22.34
